Prog stock

prog stock

Who buys prog stock?

PROG stock was bought by a variety of institutional investors in the last quarter, including Cutler Group LP, Centaurus Financial Inc., Commonwealth Equity Services LLC, and XR Securities LLC.

What is progenitys stock symbol?

What is Progenitys stock symbol? Progenity trades on the NASDAQ under the ticker symbol PROG. Who are Progenitys major shareholders? Progenitys stock is owned by a number of institutional and retail investors.

What are analystsprice targets for progenitys stock?

6 equities research analysts have issued 12-month price objectives for Progenitys shares. Their forecasts range from $2.00 to $7.00. On average, they anticipate Progenitys share price to reach $4.00 in the next year. This suggests a possible upside of 161.4% from the stocks current price.

Where can I buy progenity shares?

Shares of PROG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Progenitys stock price today?

Who bought progenity stock?

Company insiders that have bought Progenity stock in the last two years include Athyrium Capital Management, L, Damon Silvestry, Harry Stylli, and Jeffrey D Alter. View insider buying and selling activity for Progenity or or view top insider-buying stocks. How do I buy shares of Progenity?

Where can I buy shares of prog?

Shares of PROG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.

Does progenity boast high insider ownership?

In the past three months, Progenity insiders have not sold or bought any company stock. 79.30% of the stock of Progenity is held by insiders. A high percentage of insider ownership can be a sign of company health. 77.74% of the stock of Progenity is held by institutions.

What are analystsprice targets for progenitys stock?

6 equities research analysts have issued 12-month price objectives for Progenitys shares. Their forecasts range from $2.00 to $7.00. On average, they anticipate Progenitys share price to reach $4.00 in the next year. This suggests a possible upside of 161.4% from the stocks current price.

Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Progenitys stock price today? One share of PROG stock can currently be purchased for approximately $1.53.

Is progenity (prog) stock headed for a short squeeze?

(PROG) raised $100 million in an IPO on Friday, June 19th 2020. The company issued 6,700,000 shares at $14.00-$16.00 per share. Piper Sandler and Wells Fargo Securities served as the underwriters for the IPO and Baird, Raymond James and BTIG were co-managers. What is Progenitys stock symbol?

What is the price targets for progenity stock?

The average twelve-month price prediction for Progenity is $17.00 with a high price target of $42.00 and a low price target of $4.00. Learn more on PROGs analyst rating history.

Do analysts like progenity stock compared to its medical competitors?

Analysts like Progenity stock less than the stock of other Medical companies. The consensus rating score for Progenity is 2.67 while the average consensus rating score for medical companies is 2.71. Learn more on how PROG compares to other companies. Do MarketBeat users like Progenity more than its competitors?

How do analysts set stocks price targets?

When setting a stocks price target, an analyst is trying to determine what the stock is worth and where the price will be in 12 or 18 months. Ultimately, price targets depend on the valuation of the company thats issuing the stock.

What is the upside for progenitys stock?

According to analysts, Progenitys stock has a predicted upside of 723.64% based on their 12-month price targets. Sign up for MarketBeat All Access to gain access to MarketBeats full suite of research tools:

Postagens relacionadas: